AlphaYouADPT: BOBULSKY SUSAN discloses a sale
By AlphaYouPublished Form 4
BOBULSKY SUSAN
Reporting filer
BOBULSKY SUSAN reported Sale in Adaptive Biotechnologies Corp: 1195 units of Common Stock, dated 2026-09-15. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 17, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | BOBULSKY SUSAN | 2026-09-15 | S | Sale | 1195 | 27.00 | 395,794 | 2 days | Filed terms
|
Common Stock
- Owner
- BOBULSKY SUSAN
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 1195
- Price
- 27.00
- Following holdings
- 395,794
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1195
- transaction Price Per Share: 27.00
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 395794
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- BOBULSKY SUSAN: Chief Commercial Officer, MRD.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025.
Original sources
Prepared automatically from public filing data. Report a correction.